Dr Reddys Laboratories News: Read Latest News & Live Updates on Dr Reddys Laboratories, Photos, Videos at CNBCTV18.com

homeDr Reddys Laboratories News

Dr Reddys Laboratories NEWS

All

market | May 8, 2024 9:27 AM IST
Dr. Reddy's shares fall after missed earnings, top losers on the Nifty 50
photos | May 7, 2024 11:33 PM IST
Stocks to Watch: Dr Reddy's Labs, CreditAccess Grameen, Indraprastha Gas and more
india | May 3, 2024 5:58 PM IST
Dr Reddy's launches 40 mg doxycycline capsules for skin therapy in US market
business | Mar 27, 2024 5:11 PM IST
Dr Reddy's partners with Sanofi for distribution of vaccine brands in India
business | Mar 22, 2024 5:19 PM IST
Dr Reddy's partners with US-based Pharmazz to launch innovative critical care drug in India
business | Mar 21, 2024 3:57 PM IST
EXCLUSIVE | Novartis global CEO says he wants a better owner for its listed entity in India
technology | Mar 5, 2024 5:17 PM IST
Review of Dr Reddy's Nerivio Migraine Device: Medication-free headache relief
market | Mar 1, 2024 2:54 PM IST
Dr. Reddy's named as defendant in a complaint in New Jersey District court over gRevlimid
market | Feb 19, 2024 4:18 PM IST
Why Novartis' India arm and Dr Reddy's are made for each other
market | Jan 31, 2024 1:27 PM IST
Dr Reddy's shares rise to record high on gRevlimid-led beat, but analysts cautious
earnings | Jan 30, 2024 4:21 PM IST
Dr Reddy's labs Q3 results: PAT rises 10% to ₹1,379 crore; beats estimates
business | Jan 7, 2024 1:20 PM IST
Dr Reddy's recalls over 8,000 bottles of generic drug in US due to packaging error
business | Dec 29, 2023 10:44 PM IST
Dr Reddy's Laboratories acquires 6.46% stake in Edity Therapeutics for $2 million
market | Dec 11, 2023 8:51 AM IST
Dr Reddy's shares fall most in seven months after an analyst expects a warning letter for its Bachupally unit
business | Nov 16, 2023 3:55 PM IST
Dr Reddy’s rolls out wearable migraine management device in India

Dr Reddys Laboratories NEWS

Dr. Reddy's shares fall after missed earnings, top losers on the Nifty 50

Stocks to Watch: Dr Reddy's Labs, CreditAccess Grameen, Indraprastha Gas and more

Dr Reddy's launches 40 mg doxycycline capsules for skin therapy in US market

Dr Reddy's partners with Sanofi for distribution of vaccine brands in India

Dr Reddy's partners with US-based Pharmazz to launch innovative critical care drug in India

EXCLUSIVE | Novartis global CEO says he wants a better owner for its listed entity in India

Review of Dr Reddy's Nerivio Migraine Device: Medication-free headache relief

Dr. Reddy's named as defendant in a complaint in New Jersey District court over gRevlimid

Why Novartis' India arm and Dr Reddy's are made for each other

Dr Reddy's shares rise to record high on gRevlimid-led beat, but analysts cautious

Dr Reddy's labs Q3 results: PAT rises 10% to ₹1,379 crore; beats estimates

Dr Reddy's recalls over 8,000 bottles of generic drug in US due to packaging error

Dr Reddy's Laboratories acquires 6.46% stake in Edity Therapeutics for $2 million

Dr Reddy's shares fall most in seven months after an analyst expects a warning letter for its Bachupally unit

Dr Reddy’s rolls out wearable migraine management device in India